Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

U.S. to boost monkeypox vaccine supply with 1.8 million extra doses

Published 08/18/2022, 10:26 AM
Updated 08/18/2022, 04:31 PM
© Reuters. FILE PHOTO: Workers sit outside of D.C. Health's first monkeypox vaccination clinic, which is administering the first Jynneos vaccine doses distributed in the U.S. capital, in Washington, U.S., June 28, 2022. REUTERS/Gavino Garay

© Reuters. FILE PHOTO: Workers sit outside of D.C. Health's first monkeypox vaccination clinic, which is administering the first Jynneos vaccine doses distributed in the U.S. capital, in Washington, U.S., June 28, 2022. REUTERS/Gavino Garay

By Ahmed Aboulenein and Kanishka Singh

WASHINGTON (Reuters) -The United States said on Thursday it will boost its supply of monkeypox vaccine by making available an extra 1.8 million doses of Bavarian Nordic's Jynneos shot, as the number of reported cases in the country rose above 13,500.

Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), gave the figure for reported cases as of Aug.17, which represent more than a third of the global total of 39,000, at a White House briefing.

"It's critical that we do all we can to keep this dangerous virus from spreading," Secretary of Health and Human Services Xavier Becerra said at the briefing.

The Department of Health and Human Services (HHS) is making 360,000 vaccine vials available to order from next week, said Assistant Secretary for Preparedness and Response Dawn O'Connell, which is the equivalent of 1.8 million doses.

The U.S. Food and Drug Administration (FDA) last week authorized administering Bavarian Nordic's Jynneos shot intradermally, between the layers of the skin, increasing by fivefold the doses that can be used from a vial.

Bavarian Nordic has raised doubts about the safety of the method, citing a lack of data and evidence that injecting Jynneos in this way could result in increased reactions compared to injecting it underneath the skin.

The additional doses would be available for states and local health departments that administer the vaccine intradermally, and have used 90% of their current supply, White House monkeypox response coordinator Bob Fenton said.

The U.S. is also making 50,000 courses of SIGA Technologies Inc's TPOXX antiviral treatment available for people who test positive, said Fenton. State and local health departments can start ordering them next week.

In addition, President Joe Biden's administration is setting aside vaccine doses for areas hosting large gatherings of high-risk groups, he said, which state and local health departments can order on top of their existing allocations and supply.

"HHS is launching a pilot program that will provide up to 50,000 doses from the National Stockpile to be made available for pride and other events that will have high attendance of gay and bisexual men," Fenton added.

Around 98% of monkeypox cases nationwide occurred among those assigned the male sex at birth, Walensky said.

Among cases with known recent sexual history and gender, 93% were among men who reported recent sexual contact with other men, down from 99% in late July.

The pattern of sexual transmission in men is not typical. In Africa, where monkeypox has been circulating since the 1970s, 60% of cases are in men, and 40% occur in women.

© Reuters. FILE PHOTO: Workers sit outside of D.C. Health's first monkeypox vaccination clinic, which is administering the first Jynneos vaccine doses distributed in the U.S. capital, in Washington, U.S., June 28, 2022. REUTERS/Gavino Garay

Of the more than 6,000 U.S. cases for which race and ethnicity data is available, about 35% occurred among white, non-Hispanic people, Walensky said, adding that another 28% were in Black people and 33% in Hispanic people.

The median age of cases is 35, she added.

Latest comments

Ahh, so theyre cutting covid funding to pay for the new pandemic flavor of the month. Got it.
Good news is if you make responsible lifestyle choices you are pretty much safe, but you do have to help pay to vaccinate others, and at a time of high inflation.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.